Last update 07 Nov 2024

Daglutril

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
((3S)-3-{1-((2R)-2-Ethoxycarbonyl-4-phenylbutyl)cyclopentanecarboxamido}-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)acetic acid, KC 12615, KC-12615
+ [1]
Mechanism
ECE inhibitors(Endothelin-converting enzyme 1 inhibitors), enkephalinase inhibitors(Neprilysin inhibitors)
Active Indication-
Originator Organization
Active Organization-
Drug Highest PhasePendingPhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC31H38N2O6
InChIKeyXMQODGUTLZXUGZ-RPBOFIJWSA-N
CAS Registry182821-27-8

External Link

KEGGWikiATCDrug Bank
---

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetes Mellitus, Type 2Phase 2
IT
01 Jul 2005
Kidney DiseasesPhase 2
IT
01 Jul 2005
HypertensionPhase 2
AU
01 Dec 2004
HypertensionPhase 2
BG
01 Dec 2004
HypertensionPhase 2
DK
01 Dec 2004
HypertensionPhase 2
EE
01 Dec 2004
HypertensionPhase 2
DE
01 Dec 2004
HypertensionPhase 2
HU
01 Dec 2004
HypertensionPhase 2
IL
01 Dec 2004
HypertensionPhase 2
LV
01 Dec 2004
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free